Cami Gearhart's presentation on "IRB Response to Key Changes in Clinical Research Practice," focuses on current issues such as biorepositories, utilization of central IRBs, social media and emerging eConsent tools.
Seattle, WA (PRWEB) May 14, 2013
Quorum Review IRB, the industry leader in central IRB services, announces CEO Cami Gearhart, JD, as a presenter at the inaugural Forum on Optimizing Clinical Research Performance. The conference will be held in Boston, MA, May 19-21, 2013.
Ms. Gearhart will present on “IRB Response to Key Changes in Clinical Research Practice,” focusing on current issues such as biorepositories, utilization of central IRBs, social media and emerging e-consent tools. The presentation will take place Monday, May 20th at 4:45 p.m.-5:10 p.m.
Ms. Gearhart originally joined Quorum Review as a member of the IRB, and was appointed CEO in 2006. She has led the Quorum business through two AAHRPP accreditations and a successful expansion into Canada. Prior to joining Quorum Review, Ms. Gearhart practiced law in both the private sector, specializing in health care regulatory law for hospitals, clinics and other institutions, and the public sector, working for the Office of Attorney General protecting vulnerable populations. Ms. Gearhart also serves as Treasurer of the Consortium of Institutional Review Boards and Vice President for the Northwest Association for Biomedical Research’s Board of Directors.
The Forum on Optimizing Clinical Research Performance is being presented through a new strategic alliance between CenterWatch and iiBIG. This year marks the inauguration of the one-of-a-kind, strategic leadership forum that brings together sponsors, CROs, sites and other organizations. The conference provides high-quality, relevant content to all clinical research professionals. More information about the conference is available on the iiBIG website.
For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.
About Quorum Review IRB
Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing ethics review of human clinical research since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.
Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.